Health
SafePolyMed

Towards Safer Drug Treatment and Enhanced Patient Empowerment

Towards Safer Drug Treatment and Enhanced Patient Empowerment

At a Glance

  • Reducing adverse drug reactions from complex medication regimens
  • Increasing patient safety through personalised treatment plans
  • Developing AI-powered risk scores and decision-support tools for clinicians
  • Empowering patients/citizens to proactively manage their own health care

Millions of people in Europe rely on multiple medications at the same time, increasing the risk of harmful interactions and adverse effects. SafePolyMed tackles this urgent challenge by integrating large-scale real-world health and genetic data to better understand the combined impact of drug–drug–gene interactions.

The project develops AI-powered risk prediction tools and an interoperable Medication Management Center to support healthcare professionals and individuals in making safer, more informed decisions. Co-designed with people living with polypharmacy and care providers, SafePolyMed aims to empower citizens to take an active role in managing their treatment while contributing to a harmonised European approach to safer medication use.

When Treatment Turns Risky

When Treatment Turns Risky

For many people living with chronic conditions, managing their health means taking multiple medications at once. While these treatments are essential, combining them can lead to unintended consequences. The risk of harmful drug interactions and adverse effects increases with each added medicine, especially when individual factors like age, genetics, and overall health come into play. These risks can lead to serious complications, hospitalisations, and even death.

SafePolyMed addresses this challenge by focusing on how different combinations of drugs affect different people—and how those risks can be better predicted, prevented, and managed.

Smarter Data, Safer Care

Smarter Data, Safer Care

By analysing health records from over one million people, SafePolyMed explores how factors such as age, genetics, long-term conditions, and combinations of medications can affect the effectiveness of treatments, and why they sometimes cause harm.

Utilising the latest technology, including artificial intelligence, and involving patients throughout every phase of the project, the SafePolyMed team is developing digital tools that empower individuals to take greater control of their health and support more equitable, high-quality care across Europe.

The goal is to help individuals and healthcare professionals choose the safest and most effective treatments for each person, because the right medication should work for you, not against you.

safepolymed.eu

Curious to know more?
Let's start the conversation.

Your contact
Annika Enning
Dr Annika Enning
Research & Impact Manager
Portfolio Manager Health